Todd Stanhope, MD
Minnesota Perinatal Quality Collaborative

Overview of current efforts to improve outcomes for perinatal substance use in Minnesota

1) Verbal ‘Screening’ for the purpose of treatment and resourcing patients with substance use disorder and ‘testing’ of biologic specimens for illicit substances for the purpose of CPS reporting are often confused terms with significant implications 
2) Decoupling of ‘reporting’ and ‘resourcing’ can facilitate a culture of treatment (and not punishment) to optimize perinatal outcomes 
3) A perinatal quality collaborative can be an effective mechanism to align broad engagement in perinatal substance use disorder work

Lauren Graber, MD, MPH
Hennepin Healthcare Addiction Medicine

An introduction to Medications for Opioid Use Disorder (MOUD) for pregnant people, including methadone and buprenorphine, approaches to buprenorphine initiation, and tips for pain management in this population.

1. Impact of Perinatal Substance Use
2. Choosing MOUD that’s best for your pregnant patient
3. Spotlight on buprenorphine
4. Spotlight on perinatal pain management

Erin Foss, RN, CARN Stratis Health

This session will provide simple and practical modifications that can be made to the language and workflow used in the Perinatal care continuum.

1) Define stigmatizing language that may impact care

2) Discuss efficient workflow to support positive patient outcomes

3) Develop customized approaches in multimodal patient centered care

Melissa C. Bray-Iverslie MSN Ed., BSN, FNP-C, RNC-MNN, PHN and Mallory Cummings, RN

Learn how birthing people in Minnesota are being educated and empowered to self-advocate for their own heart health while helping to alert other healthcare providers who may not be as familiar with pregnancy related hypertension by expediting care via medical alert bracelets.

Objectives:
1. Understand the significance of hypertension and why it is important to recognize and treat gestational related hypertension quickly and appropriately
2. Learn about a new novel method to engage patients, family, and community in the health and well-being of birthing people in Minnesota
3. Learn how to implement the Blue Bands at your hospital, clinic, facility, or organization

Charles Schauberger, MD

After a brief review of our knowledge basis for cannabis use in pregnancy, we will explore care options for patients who use cannabis in pregnancy and postpartum.

1. We need to understand the current science of cannabis in pregnancy.  This will be reviewed. 
2. We need to understand the concept of harm reduction as it relates to cannabis use in pregnancy. 
3. Contingency management may represent one strategy for limiting cannabis use in pregnancy.  We will discuss this option.

Jessica Schwartz, RN, CARN
Essentia Health

Practical tips and lessons learned to build a patient centered, harm reduction based substance use disorder program.

1. Describe organizational tools to improve patient care and provider workflow.
2. Designate key stakeholders at various levels of leadership and clinical are to participate in programmatic development.
3. Advocate for clinical program policies to align with evidence based harm reduction practices to increase patient engagement in care.

Rachel Cooper, MD
MOSTaRE Faculty Lead, Sanford Health

An overview of the Eat Sleep Console program and how it was successfully implemented at a community hospital with a very high volume of opioid exposed infants. 

1. “Traditional” NAS treatment
2. Basics of Eat Sleep Console
3. Challenges with ESC Implementation
4.Questions/Discussion 

Lauren Graber, MD, MPH
Hennepin Healthcare Addiction Medicine

Review the current MN legal statutes that affect pregnant patients with substance use and an approach to drug testing before and after delivery.

1. Review current state and federal statutes affecting pregnant patients with substance use 
2. Considerations for drug testing during pregnancy and at delivery 
3. Discuss best practice for perinatal care in the context of current state and federal statutes

Valerie Gustafson, MPS LADC
Hennepin Healthcare Addiction Medicine

Leslie Carranza MD, MHS
Mayo Clinic

In this highly interactive session participants will observe recordings of clinicians discussing three adverse/harm events with standardized patients (SP). Participants will also observe coaches prepping these individuals for the conversations. Participants will receive a “Communication Tip Sheet” and “Harm Communication Coaching Guide.”

1. Describe the reasons why effective communication with patient and families after harm events is a key clinical skill and articulate the basic elements of harm communication discussions ​  ​ 
2. Explain the fundamental elements of the harm communication coaching model and outline the essential skills involved with harm communication coaching.

Kurt DeVine, MD, FASAM 
CentraCare Addiction Services, Stratis Health

I will present options for treatment including medications for AUD in pregnancy, as well as current recommendations regarding benzodiazepine use and prescribing.

Understand the risks of Alcohol and Benzodiazepine use during pregnancy.  Be aware of general guidelines of treatment, both acute and chronic to improve outcomes.

Bethany Sabol, MD MAS Assistant Professor Department of Obstetrics, Gynecology & Women’s Health Division of Maternal-Fetal Medicine University of Minnesota, MHealth Fairview

This session will provide a brief overview of obstetrical emergencies and provide attendees with practical tips for how to best plan and prepare for these situations on our obstetrical units.

1. Define common obstetrical emergencies and evidence-based protocols for response
2. Discuss key components to multidisciplinary teamwork and communication during an emergency
3. Discuss how to create simulations for obstetrical emergencies on your unit
4. Review key resources and brainstorm actionable items for enhanced preparedness

Brian Grahan, MD, PhD
Hennepin Healthcare

Meagan Thompson, DNP, APRN, CNM, PMHNP-BC
University of St. Thomas

Discuss approaches to measuring success in the care of pregnant individuals with problematic substance use

1. Identify national standards of care for people with perinatal substance use disorders  
2. Define short- and long-term approaches to measuring success  
3. Discuss methods of measuring success and how they can be applied to your institution.

Discuss approaches to measuring success in the care of pregnant individuals with problematic substance use

Identify national standards of care for people with perinatal substance use disorders Define short- and long-term approaches to measuring success Discuss methods of measuring success and how they can be applied to your institution

Corey Martin, MD
Our mindset and how we approach situations have significant implications for our health, happiness, and patient outcomes.  Dr. Martin talks about the science behind mindset and how our mindset of stress impacts our work, our health and the people around us.
Objectives:
1. Understand the role of mirror neurons in our emotional health   
2. Understand the role mindset plays in stress   
3. Identify at least 3 ways that mindset can improve health and wellbeing

$2,000

• Complimentary registration for four people to attend conference (includes meals)
• Recognition throughout the conference including logo on conference signage, brochure, etc.
• Complimentary vendor table at conference
• Sponsored speaker for breakout session

$1,000

• Complimentary registration for two people to attend conference (includes meals)
• Complimentary vendor table at conference

Refunds and cancellations

If written notice of cancellation is received one month prior to the event, a refund less a $200 administrative fee will be made.

501C3 non-profits or universities, are eligible for a 40% discount on sponsorship.